Taking people1/2. fázis
Phase 1b/2 Dose-Ranging Study of the Safety, PK, PD & Efficacy of the Activin Signaling Inhibitor HS235 vs placebo added to background therapy in PAH (SEASIde)
Key facts
- Where
- Budapest VIII és Szeged, MagyarországSee the 2 sites
- Phase
- 1/2. fázis
Where in Magyarország
- Semmelweis UniversityBudapest VIII, MagyarországToborzás még nem indult
- University of SzegedSzeged, MagyarországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- 35Pharma Inc.
- Trial code
- EU 2025-523010-89-00
- Record updated
- 2026. október 26.